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Abstract 
Background: Studies of epigenetics and transcriptional activity in adolescents may provide 
knowledge about possible preventive strategies of depression.  
Methods: We present a methylome-wide association study (MWAS) and cohort validation 
analysis of depression in adolescents, in two separate cohorts: discovery (n=93) and validation 
(n=78). The genome-wide methylation pattern was measured from whole blood using the 
Illumina 450K array. We performed a MWAS by robust multiple linear regressions of 
methylation to a modified risk-score assessment of depression, adjusting for optimally 
determined co-variates. Candidate CpG loci were further investigated in a separate cohort of 78 
adolescents. Methylation levels of candidate CpG sites were correlated with expression levels 
of the associated gene in an independent cohort of 11 healthy volunteers.  
Results: The methylation state of two CpG sites reliably predicted ratings of depression in 
adolescents (cg13227623 and cg04102384) (p<10-06). In a cohort validation analysis, 
cg04102384 – located in the promoter region of microRNA 4646 (MIR4646) - was confirmed 
to be hypomethylated in depressed subjects (p<0.05). We provide evidence for an inverse 
correlation between cg04102384 methylation levels and expression levels of MIR4646-3p 
(p<0.05) in healthy controls.  
Limitations: MIR4646 was not differentially expressed in a subset of samples with adolescent 
depression measured by qRT-PCR measurements. 
Conclusion: We identify and confirm a specific MIR4646 associated epigenetic risk site to be 
associated with depression in adolescents. Cg04102384 putatively regulates gene expression of 
MIR4646-3p. Target gene prediction and gene set overrepresentation analysis revealed 
involvement of this miRNA in fatty acid elongation, a process related to omega-3 fatty acids, 
previously associated with depression. 
 Keywords: MIR4646; methylome-wide association study; adolescent depression; omega-3; 
microRNA 
 
 
Introduction 
Depressive disorders are highly prevalent during the adolescence and are associated with a 
higher risk for suicide, antisocial behavior, substance abuse, significant impairment and an 
increase of functional disability (Glied & Pine, 2002). Major depression (MDD) is common in 
young people, affecting up to 5-6% of the adolescents (Costello, Erkanli, & Angold, 2006). 
Moreover, a reliable detection of early onset depression is of high importance as a solid 
diagnosis during adolescence would help to efficiently unveil people at risk for depression at 
later stages of life (Birmaher, Arbelaez, & Brent, 2002). However, the exact mechanism that 
underlies the high risk for depression during the youth is poorly understood. Investigating the 
relationship between the MDD risk as evaluated by the Development and Well-being 
Assessment (DAWBA), epigenetics mechanism and transcriptional activity in adolescents may 
provide knowledge of preventive strategies of depression among adults.   
In recent years, there has been increasing interest to elucidate the role of epigenetic 
modifications in the pathogenesis of psychiatric disorders (D’Addario et al., 2012; Dell’Osso 
et al., 2014; Ruzicka, Subburaju, & Benes, 2015; Walker et al., 2016). In this context, especially 
changes in the methylation at CpG dinucleotides within regulatory regions of the DNA were 
studied, which were shown to be responsive to environmental signals by modifying the 
transcription of genes (Cordova-Palomera et al., 2015). Notably, the importance of altered gene 
expression in MDD was recently demonstrated in a study where genes, such as DVL3, CALM1 
and NMUR1 were differentially expressed in depressed individuals (Jansen et al., 2015), 
resulting in a new complementary mechanistic insight. Moreover, DNA methylation has been 
associated with other genomic functions, such as alternative splicing and promoter usage 
(Maunakea et al., 2010), which lead as well to a transcriptional modulation of MDD related 
genes. 
Dysregulation of epigenetic control is particularly interesting in the context of MDD 
development (Menke & Binder, 2014), as the pathogenesis of this disease is characterized by a 
tight gene-environment interplay that influences neurobiological processes underlying the 
disease (Nugent, Tyrka, Carpenter, & Price, 2011; Schmitt, Malchow, Hasan, & Falkai, 2014). 
Importantly, depressive symptoms are thought to have an incidence spike during adolescence 
(Birmaher et al., 2002), suggesting a long-term importance for investigating the epigenetic 
changes during this time frame. Previous targeted studies suggested that the methylation profile 
of the BDNF gene could serve as biomarker of late-life depression (V Januar, Ancelin, Ritchie, 
Saffery, & Ryan, 2015). Furthermore, another study highlighted altered DNA methylation of 
the serotonin transporter (5-HTT) gene in depressed adolescents (Olsson et al., 2010). A recent 
genome-wide study identified differentially methylated loci between medication-free depressed 
individuals and non-psychiatric controls in blood, but the study was not corrected for cell-type 
heterogeneity (Numata et al., 2015), meriting further research in medication-free subject taking 
cell heterogeneity into account. The abundance of cell populations is relevant through their 
distinct signatures of DNA methylation (Reinius et al., 2012) that could induce false differences 
between depressed individuals and controls. Also, an epigenome-wide study reported 
differences of PRIMA1 gene methylation between depressed adults and controls. However, the 
authors were not able to replicate the findings in their additional samples (Sabunciyan et al., 
2012). 
 Another attractive candidate mechanism to induce phenotype-associated changes is related to 
small non-coding RNAs (miRNA) which play a critical role in post-transcriptional fine-
regulation of gene expression in many different tissues, including human brain functioning 
(Wei Chen & Qin, 2015). There is evidence suggesting an interaction between miRNA 
expression and psychiatric disorders, possibly mediated by DNA methylation (Villela et al., 
2016). Due to the miRNAs role in degrading and/or inhibiting translation, a better 
understanding of the interaction between shifts in DNA methylation and a changed miRNA 
expression would provide additional valuable information about mechanistic links between 
methylation and depression. 
Herein, we set out to identify the role of DNA methylation between whole-blood samples of 
adolescents at high risk for depression and controls in an unbiased methylome-wide approach, 
using the 450K Illumina array. The identified differentially methylated loci were further 
replicated in an independent cohort of depressed adolescents. We detect the gene encoding 
MIR4646 as significantly differentially methylated and investigate its change in expression 
further in an independent cohort of healthy controls. Lastly, we measure the miRNA levels for 
a sub-sample of the discovery data set and observe the expression change between adolescents 
at risk of depression and controls.  
 
 
 
 
Methods 
Discovery data set 
The study of the Discovery data set was approved by the local ethics committee in Uppsala, 
Sweden (Regionala etikprövningsnämnden i Uppsala) and included 93 adolescents aged 14 to 
17, recruited in the years 2013-2014. Both subjects and their participating parent(s) gave their 
written informed consent to participating in the study. Subjects were randomly selected from 
public school in Uppsala County and were included in the study if they exhibited an overall risk 
for psychiatric diagnoses of 15% or more, as measured by the DAWBA web-based diagnostic 
interview (described below (Goodman, Heiervang, Collishaw, & Goodman, 2011)). Self-
reported information pertaining to basic physiological parameters and medication was provided 
by the participants. Body weight was measured for body mass index (BMI) calculation. The 
BMI z-scores were calculated and based on these values each subject was stratified into one of 
four weight category groups (underweight, normal weight, overweight and obese), as defined 
by the Center for Disease Control and Prevention (CDC). Subjects were grouped into three 
categories based on their DAWBA risk-score assessment for depression as ‘Controls' (~ 0-3%), 
'15% Risk Depression' (~ 15%)  and 'Depressed' (~50-75%), respectively. 
Replication data set 
In the replication stage, 130 samples from the study mentioned above, but characterized and 
measured earlier in the time frame between November 2012 and January 2013, were studied. 
The study was approved by the local ethics committee in Uppsala, Sweden (Regionala 
etikprövningsnämnden i Uppsala) and all participants and their parent(s) gave their written 
informed consent. This data set is population-based and the same parameters were recorded as 
for the Discovery data set. In order to increase the power to detect meaningful differences, we 
excluded subjects with intermediate risk scores for any psychiatric disorder, and stratified the 
remaining individuals into one of two categories: ‘Controls’ (~0%) and ‘Depressed’ (~15-50%). 
Psychiatric Diagnoses  
The DAWBA consists of web-based diagnostic interviews used to evaluate DSM-IV and ICD-
10 type diagnoses specifically for individuals in the age range 5 to 17 years. The questionnaire 
is completed separately by both a parent and the child, and encompasses the most prevalent 
behavioral, emotional and hyperactivity type disorders. The covered categories include 
depression, generalized anxiety disorder, SAD, post-traumatic stress disorder (PTSD), autism 
and obsessive compulsive disorder (OCD). We used an algorithm to convert questionnaires to 
probability of diagnosis, ranging from less than 0.1% to 70% and reflecting the probability that 
an experienced clinical rater would assign the individual a corresponding DSM-IV or ICD-10 
diagnosis (Goodman et al., 2011).  
DNA Specimens  
Body weight was measured and participants answered a questionnaire with questions about 
living conditions, place of birth and basic physiological parameters (height, age etc.). Venous 
blood was taken according to standard procedures and stored in six tubes at a total volume of 
25 ml comprising two EDTA coated tubes for DNA extraction, two PAX gene tubes for RNA 
extraction, one lithium-heparin treated tube for plasma and one substrate-free tube for serum. 
All tubes were kept at minus 80°C after separation of plasma and serum by centrifugation. 
Methylation Profiling  
DNA was extracted using the phenolol-chloroform method (Sambrook, Fritsch, & Maniatis, 
1989), and bisulfite converted by the EZ DNA Methylation - GoldTM kit (ZymoResearch, 
USA). Bisulfite converted DNA was hybridized to the Illumina 450k methylation chip 
(Illumina, San Diego, CA, USA). The Illumina chip measures methylation at 485 777 CpG 
sites. The Illumina iScan system (Illumina, San Diego, CA, USA) was used for imaging of the 
array, whereby the methylation level of each CpG site was determined. 
Data Preprocessing and Quality Control  
Preprocessing of the methylation data was performed by adjustment of probe type differences, 
removal of batch effects and probe exclusion. Subsequently, principal component analysis 
(PCA) was used to identify sample outliers in the methylation data. Methylation preprocessing 
steps were performed in using R statistics (ww.r-project.org) together with the packages minfi 
(Aryee et al., 2014), wateRmelon (Schalkwyk, Pidsley, & Wong, 2013), ChAMP (Morris et al., 
2014), sva (Leek, Johnson, Parker, Jaffe, & Storey, 2012), and limma (Smyth, 2004) of the 
Bioconductor project and the FactoMineR (Lê, Josse, & Mazet, 2008) package of the CRAN 
project. Concerning adjustment of probe type differences, removal of batch effects, probe 
exclusion and sample exclusion criteria please see Supplementary material. 
Accounting for cellular heterogeneity 
DNA methylation measured in whole blood is composed of different cell populations (Reinius 
et al., 2012). Rask-Andersen et al. demonstrated recently that changes in leukocyte fractions 
could introduce considerable variability in the DNA methylation pattern which could bias 
downstream analyses. Thus, it is important to take into account white blood cell type 
heterogeneity in genome-wide DNA methylation studies (Rask-Andersen et al., 2016). In the 
Discovery and Replication group, we implemented a minfi-based statistical procedure of the 
Houseman algorithm (Aryee et al., 2014), which uses raw intensity DNA methylation files to 
calculate the relative proportions of B cells, CD4+ and CD8+ T cells, granulocytes, 
monocytes, and natural killer cells. 
 
Micro-RNA profiling 
Sample inclusion considerations 
Candidate microRNAs were investigated by measuring their expression levels in whole blood. 
For this purpose, we extracted RNA from a group of 27 subjects comprising eleven ‘Controls’, 
nine ‘15% risk depression’ and seven ‘Depressed’ individuals from the Discovery data set. 
Samples were selected based on their level of DNA methylation at the associated methylation 
locus (cg04102384). In order to increase the power to detect meaningful associations, we 
selected the eleven controls with the lowest methylation levels, and 16 cases (‘15% Risk 
Depression’ or ‘Depressed’) with the highest methylation levels. 
 
Reverse transcription and quantitative real-time PCR.  
To measure miRNA expression, 10 ng of extracted RNA was reverse transcribed into cDNA 
using a TaqMan® miRNA Reverse Transcription Kit (Applied Biosystems, Waltham, MA, 
USA) and specific stem-loop reverse transcription primers (TaqMan® MicroRNA Assays 
MIR4646-3p and MIR4646-5p; Life Technologies, Carlsbad, CA, USA). RT-PCR was 
performed using 0.67 µl cDNA and 9.3 µl RT-PCR Universal Fast Master Mix (Applied 
Biosystems) including primers. U6snRNA/RNU44 was used as an internal control. All 
measurements were performed in triplicate. 
Characterization of the expression data set 
Eleven healthy male volunteers aged between 18 and 40 years were recruited from the region 
of Uppsala, Sweden, between 2013 and 2014. Blood analyses were performed before and after 
a meal intake. For the purpose of this study, only the non-fasting blood samples were further 
studied. The data was adjusted for white blood cell type heterogeneity. More details on the 
cohort and preprocessing of the methylation and RNA specimens have been previously 
published (Rask-Andersen et al., 2016). 
Statistical analysis    
All statistical analyses were performed in using R statistics, version 3.3.0. 
Data analysis 
Chi-squared tests with Monte Carlo computed p-values were used to detect differences in 
categorical variables, e.g. gender, BMI group (underweight, normal weight, overweight and 
obese), use of medications (sleep medications, neuroleptics, contraceptive pills, anxiolytics, 
ADHD medications and antidepressives) and the DAWBA risk score for any psychiatric 
disorder. In the Discovery group, ANOVA tests were used to investigate group differences in 
age. In the Replication group, which was stratified into two DAWBA groups, we used t-tests 
to investigate group differences in age. 
Adjusting for potential confounders 
In methylome-wide association studies, hidden confounders such as life style patterns or even 
prandial states can introduce unknown sources of bias. Drawing on a method for epigenome-
wide analyses introduced by Zhagool et al. (Zaghlool et al., 2015), PCA-analysis was used to 
account for potential unmeasured sources of variation in the DNA methylation data using the 
MethylPCA tool (Wenan Chen et al., 2013). The known covariates (including age, gender, 
weight category, the relative proportions of white blood cell types and the DAWBA overall 
risk score for any psychiatric disorder) were regressed out prior to PCA. The calculated first 
ten principal components were considered as additional potential covariates in the 
methylome-wide analysis. 
There were many potential covariates on the association analysis between DNA methylation 
and depression risk score, e.g. gender, age, self-reported use of medication, the white blood cell 
coefficients and the first ten principal components. To avoid overfitting by including too many 
covariates, we investigated each individual covariate against the phenotype of interest in 
regression models using the ‘lm’ function in R. Covariates were incrementally and 
independently selected. Using the computed analysis of variance, we tested whether the 
addition of a particular covariate resulted in a better fit to the model and only included variables 
with a p-value < 0.05. The best linear model for depression risk score included the CpG sites, 
risk score for any psychiatric disorder (p<0.00001), self-reported use of ADHD medication 
(p=0.022), the relative proportion of CD4+ T cells (p=0.017) and the first principal component 
(p=0.00081). For statistical analysis, we transformed the beta values to M-values, which have 
been shown to be statistically more robust (Du et al., 2010). 
Methylome-wide association study  
The association between DNA methylation and depression was tested by linear models using 
the ‘limma’ package for R, applying an empirical Bayes method based on a moderated t-statistic 
(Smyth, 2004). We assumed a linear model where the M values of each CpG site were used as 
a quantitative dependent trait and the phenotype characterizing the risk for depression were 
used as covariates together with the other optimal covariates.  
We used the package 'GenABEL' available for R to calculate the genomic inflation factor 
lambda for the epigenome-wide analysis (Aulchenko, Ripke, Isaacs, & van Duijn, 2007) to 
evaluate whether a general systemic inflation of significance values was abundant. In 
accordance to Zhagool et al. (Zaghlool et al., 2015), we first tested whether the calculated 
optimal covariates resulted in less systemic inflation as compared to limiting the covariates to 
age, gender and BMI z-score weight category. Using the optimal covariates in the methylome-
wide association analysis between DNA methylation and depression risk score reduced the 
genomic inflation factor lambda from 1.95 to 1.11. To exclude any potential bias from systemic 
inflation of significance values (lambda > 1 in this case), all subsequent chi-squared statistics 
on a set of candidate markers were divided by lambda (Hinrichs, Larkin, & Suarez, 2009). For 
each CpG site, we thus divided the regression t-value by lambda, and used the adjusted t-values 
to test for significance based on the t distribution. The inflation factor lambda for the adjusted 
p-values was estimated to be ~0.90, and systemic inflation of significance values was excluded. 
We used the bonferroni method correct for multiple testing.  Bonferroni and lambda-adjusted 
p-values < 0.05 were considered significant.  
Investigation of candidate CpG-sites in the Replication data set 
In the Replication data set, we performed independent samples t-tests of candidate CpG-sites, 
contrasting methylation between cases and controls and taking the direction of the methylation 
change into account.  
Correlation analyses between methylation and expression data 
CpG sites consistently hyper- or hypomethylated in the Discovery and Replication data set were 
further investigated with regard to an association with transcriptional expression of the 
microRNA in focus using the Expression data set. We performed Spearman correlations of 
methylation M-values to normalized expression levels of probes associated with the candidate 
miRNA, assuming an inverse correlation. P-values < 0.05 were considered significant. 
We also measured the miRNA levels of MIR4646-3p and MIR4646-5p by TaqMan analysis in 
26 subjects from the Discovery data set and studied methylation-expression correlations by 
Spearman’s rank correlation.  
Differential expression analysis of MIR4646-3p/5p in a subset of samples from the Discovery 
data set 
In the 26 subjects for whom miRNA levels were measured, we studied potential differences in 
normalized expression levels between the defined depression groups by ANOVA models, not 
taking any co-variates into account.  
Functional analysis of the identified CpG site via chromatin states and long-
range interactions 
In order to illustrate the functional role of the identified CpG site in brain, as well as its potential 
regulatory effect on other genes, we performed chromatin states and long-range interactions 
analyses using the ENCODE project. The analysis uses Hidden Markov Models (HMMs), 
which were applied to seven brain regions, i.e. brain angular gyrus (BrainAG), brain anterior 
caudate (BrainAC), brain cingulate gyrus (BrainCG), brain hippocampus (BrainHIPPO), brain 
inferior temporal lobe (BrainITL), brain substantia nigra (BrainSN) and brain dorsolateral 
prefrontal cortex (BrainDPC), together with peripheral blood mononuclear primary cells 
(PBMC). As a result, an 18-state model was obtained, which, for simplicity, was reduced to 
five regions defining the relevant gene regulatory roles, which were indicated as (1) red, for 
active/flanking active/bivalent/poised transcription start site (TSS), (2) yellow, for 
active/bivalent/genic enhancer; orange, for flanking bivalent TSS/enhancer, green, for active 
transcription and grey, for repressed polyComb state (Figure 3.). The long-range interactions 
were investigated using chromatin analysis by paired-end tag sequencing (ChIA-PET). Several 
cell lines were used for the analysis, including erythrocytic leukaemia cells (K562), breast 
cancer (MCF-7), cervical cancer (HelaS3) and human colon carcinoma (HCT-116) cells, 
targeting the transcription factors RNA polymerase II and CTCF. Data was downloaded from 
the WashU Epigenome Browser, 37/hg19 version. 
Target gene prediction and pathway analysis of MIR4646-3p 
Candidate CpG-sites associated with microRNAs were further investigated by computationally 
predicting putative gene targets of the aforementioned miRNAs using the online webtool 
MiRWalk 2.0 (Dweep, Sticht, Pandey, & Gretz, 2011), a sophisticated online software tool that 
documents predictions from several independent prediction algorithms, including Targetscan 
(Grimson et al., 2007),  DIANA-microT-CDS (Paraskevopoulou et al., 2013), miRandarel2010 
(Betel, Koppal, Agius, Sander, & Leslie, 2010) and RNAhybrid (Rehmsmeier, Steffen, 
Hochsmann, & Giegerich, 2004). MiRNA targets were considered as relevant hits when having 
a seed length ≥ 7 bases and when located within the 3′-UTR region. Genes identified as putative 
miRNA targets were further investigated by overrepresentation analysis of KEGG-defined 
pathways, using the online web tool ‘ConsensusPathDB-human’ (Kamburov, Stelzl, Lehrach, 
& Herwig, 2013). 
Alignment and syntetic conservation across species 
A thorough search of miRNA-4646 was performed in the miRBase database (release 21) 
using the webserver (Kozomara & Griffiths-Jones, 2014).  A BLASTn (Boratyn et al., 2013) 
search was performed through the NCBI Blast webserver (v. 2.5.0) using the NCBI Genomic 
Reference Sequences dataset with word size 16 and all other parameters default values. The 
relevant hits were retained considering e-value (> 5e-06), sequence identity and appropriate 
sequence coverage, i.e., if the seed regions of the mature miRNAs were covered. The 
sequence region of interest for Homo sapiens (NC_000006.12) , Pan troglodytes 
(NC_006473.4), Pan paniscus (NW_014013975.1), Gorilla gorilla gorilla (NC_018430.1), 
Pongo abelii (NC_012597.1), Nomascus leucogenys (NC_019816.1), Macaca mulatta 
(NC_027896.1), Papio anubis (NW_003873063.1), Saimiri boliviensis (NW_003943814.1), 
Callithrix jacchus (NC_013899.1), Aotus nancymaae (NW_012186114.1), Mandrillus 
leucophaeus (NW_012106809.1), Rhinopithecus bieti (NW_016820117.1), Colobus 
angolensis palliates (NW_012115555.1), Cebus capucinus imitator (NW_016107339.1), 
Cercocebus atys (NW_012003394.1) were downloaded and then aligned using the Mafft 
webserver (v 7)  (Katoh & Standley, 2013) with the L-INS-i method, allowing to adjust 
sequence direction, and all other settings default. Visualization with nucleotide coloring 
scheme and manual editing of the alignment was performed in Jalview (Waterhouse, Procter, 
Martin, Clamp, & Barton, 2009) with further refinements performed in Adobe Illustrator. The 
Sequence-Structure Motif Base: pre-miRNA prediction webserver 
(http://www.regulatoryrna.org/webserver/SSMB/pre-miRNA/home.html) was used to assess 
if the identified genomic region in each investigated species was predicted to form pre-
miRNA. The species phylogeny tree was created using phyloT (Letunic & Bork, 2016) and is 
based on NCBI taxonomy.  The tree represents the evolutionary relationship among the 
investigated organisms; the branch lengths are not relative to evolutionary distances. The gene 
synteny was gleaned through the NCBI map view web portal (O’Leary et al., 2016).  
 
 
 
 
 
 
 
 
Results 
Behavior of the clinical outcome variables 
In the Discovery data set, comprising 93 subjects and in the majority female, we initially aimed 
to identify CpG-sites, in which modifications of the epigenetic profile are associated with a 
modified risk score of depression. There were no significant differences between the three 
DAWBA sub-groups (‘Controls’, ‘15% Risk Depression’ and ‘Depressed’) in age, gender, BMI 
z-score derived weight categories, in the use of medications or in the relative proportion of 
white blood cell type coefficients (CD4+ and CD8+ T cells, B cells, monocytes, NK cells, and 
granulocytes). As expected, the ‘Depressed’ subgroup had significantly higher DAWBA 
general risk score estimates for any psychiatric diagnosis (p<0.001). The Replication data set 
of 78 subjects included only female subjects. Depressed cases showed a higher BMI (p<0.01), 
took more often contraceptive pills (p<0.01) and scored higher in the DAWBA general risk 
score for any psychiatric diagnosis. There were no between-group differences in age, the 
relative proportion of white blood cell types or in the use of non-contraceptive medications 
(Table 1.).  
Two CpG sites in proximity to ZWIM5 and MIR4646 are differentially 
methylated by depression risk score group 
We performed multiple linear regression models of methylation M-values and depression risk 
group, to study the association between DNA methylation and a three-factorial risk score of 
depression in the Discovery data set, adjusting for the identified optimal covariates, comprising 
the DAWBA general risk score assessment of any psychiatric disorder, ADHD medication, 
relative proportion of CD4+ T-cells and the first principal component. This procedure 
effecticiently reduced the systemic inflation of significance values from 1.95 to 1.11, as 
evaluated by the lambda genomic inflation factor (Figure 1a-1b.). A potential bias through 
systemic inflation of significance values was successfully removed by adjusting the t-values for 
the lambda of 1.1, resulting in a new lambda of 0.9 (Figure 1c.). Additionally, Bonferroni-
correction was applied on the lambda-adjusted significance values.  Two CpG sites were proven 
to be differentially methylated by depression risk score group (cg13227621 and cg04102384), 
associated with the genes ZWIM5 and miRNA MIR4646 (pBonf<0.05)(Table 2.) (Figure 2.). 
Methylation of cg04102384, which is associated with a modified DAWBA 
score of depression, is also hypomethylated in the replication data set 
Hypomethylation of cg04102384, which was found to be associated with depression risk score 
in the Discovery data set, was confirmed to be hypomethylated in whole blood of the group of 
thirteen subjects with higher risk scores for depression as compared to the controls (replication 
data set)(Table 3., p<0.05). Cg13227621 was not differentially methylated in relation to 
DAWBA.  
CpG site methylation of cg04102384 is negatively correlated with expression 
of MIR4646-3p 
To evaluate to what extent the methylation of cg04102384 is associated with the expression of 
the adjacent microRNA, Spearman correlations were performed using the Expression data set 
of eleven non-fasting healthy controls. The methylation state and the level of transcriptional 
miRNA expression were compared intra-individually to each other, assuming a negative 
correlation. Cg04102384 significantly inversely correlated with transcriptional levels of 
MIR4646-3p (p<0.05), but not with the transcriptional expression of MIR4646-5p or pre-
miRNA levels of MIR4646.  
To confirm these findings, we performed Taqman analysis, individually measuring the 
expression levels of MIR4646-3p and MIR4646-5p in 27 subjects from the Discovery data set 
(eleven ‘Controls’, nine ‘15% Risk Depression’ and seven ‘Depressed’). There were no 
between-group differences in expression levels of either of the two microRNAss. Nor could we 
confirm an association between methylation and expression by Spearman’s rank correlation 
method for either of the two miRNAs and the candidate CpG site.  
A significant overrepresentation of has-miR-4646-3p putative gene targets 
are involved in biological processes associated with fatty acid elongation and 
biosynthesis of unsaturated fatty acids 
Using the MirWalk2.0 analysis software(Dweep et al., 2011), we retrieved the predicted gene 
targets for has-miR-4646-3p. 552 genes were identified as putative gene targets for has-miR-
4646-3p and were subsequently investigated by overrepresentation analysis of KEGG-defined 
pathways. There was a statistically significant overrepresentation of genes associated with fatty 
acid elongation (6 genes, q-value<0.01) and biosynthesis of unsaturated fatty acids (5 genes, q-
value<0.05).  
The CpG site next to the gene MIR4646 may have a regulatory role in brain 
and even modulate other genes 
The investigation of the chromatin regions overlapping our CpG locus, cg04102384, revealed 
a regulatory role throughout all investigated brain regions, except brain cingulate gyrus. This 
CpG site is located in an enhancer region in blood, angular gyrus, dorsolateral prefrontal cortex, 
inferior temporal lobe and anterior caudate, and even in a TSS region in hippocampus and 
substantia nigra. Furthermore, the long-range interactions for this CpG site, represented by arcs 
(Figure 3.), refer to possible regulatory effects on multiple other genes, e.g. CLIC1 and BAG6.  
MIR4646 appears to be evolutionary conserved from the advent of 
Simiiformes (monkey) 
The miRNA-4646 stem-loop region is identified only in Homo sapiens in the mirBase 
database and a BLASTn search in the NCBI webserver was used to investigate if this region 
is conserved in other species. Sixteen relevant hits were obtained with particular emphasis on 
the conservation of the seed regions. The conservation throughout the seed regions and the 
mature 5p and 3p regions are presented in the multiple sequence alignment (Figure 4; Part 
A).  All sixteen sequences are predicted to fold into a pre-microRNA folding structure, i.e., 
hairpin loop. The gene synteny (Figure 4; Part B) is conserved among 13 of the 16 species 
investigated, except for variation in the number of LY6G6C/6D/6E/6F genes.  Several of the 
species did not have an available mapped genome through the NCBI map view, or the 
mapping was incomplete. The reverse complement of the miRNA-4646-3p mature sequence 
had nine relevant hits with the miR-204 family when searched in the miRBase database. The 
conservation of the mature miRNA with the seed region emphasized is presented in the 
multiple sequence alignment (Figure 5). 
 
 
 
 
 
Discussion 
Using a methylome -wide study approach, we identified two genes, ZSWIM5 and MIR4646, to 
be differentially methylated in whole blood of 93 adolescents in association with a modeled 
risk score for MDD. To the best of our knowledge, this is the first study investigating genome-
wide DNA methylation shifts in relationship to MDD in a population-based cohort of 
adolescents (Vania Januar, Saffery, & Ryan, 2015). We were able to validate our finding in an 
independent data set of 78 adolescents and could also show that that the methylation drift of the 
MIR4646 associated CpG locus was inversely correlated with the degree of gene expression in 
healthy individuals. Thus, we detect miR-4646 as a novel marker for risk of MDD in 
adolescence, a critical period for environmental experience, and could add value in planning 
the preventive and control strategies for adulthood MDD.  
We detect hypomethylation of cg04102384 – a methylation locus located within 246 bp of the 
transcriptional start site for MIR4646 - and the risk of depression in adolescents. By further 
investigating associations between methylation and expression in healthy individuals, we 
provide evidence that the level of methylation at this CpG site regulates expression of 
MIR4646-3p in whole blood, underlying the functional importance of this locus. Our functional 
analysis revealed that the MIR4646 associated CpG site is located in an enhancer region of the 
gene throughout all investigated brain tissues, as well as in peripheral blood cells (see Figure 
3). These homogenous findings for both brain tissue and blood are of importance as it underlines 
the applicability/transferability of epigenetic findings made in blood on changes putatively also 
abundant in brain in addition to the correlations between blood and brain methylomes(Hannon, 
Lunnon, Schalkwyk, & Mill, 2015; Nikolova et al., 2014). Moreover, in the MDD context, the 
whole blood methylation analysis may be relevant (Walker et al., 2016) particularly for the 
multiple pathophysiological pathways associated with this disease, e.g. inflammatory 
(Zunszain, Hepgul, & Pariante, 2013), immune (Blume, Douglas, & Evans, 2011) and 
metabolic processes (Vogelzangs et al., 2014). 
Strikingly, MIR4646-3p appears to play a role in the neurobiological context, as detected by 
KEGG pathway annotation. In our study, we identify that MIR4646-3p is associated with the 
elongation of fatty acids. Importantly, this process mediates the conversion of omega-3 fatty 
acids, e.g. the eicosapentaenoic (EPA) and docosahexaenoic (DHA). Essential omega-3 fatty 
acids cannot be synthesized by the organism and have to be taken up by the diet, from sources 
as fish, eggs and soy products. They were shown to be involved in brain functioning, 
particularly in memory and cognitive performance (Ruxton, Reed, Simpson, & Millington, 
2004). Interestingly, omega-3 fatty acids appear to be implicated in MDD pathophysiology 
(Hibbeln, 1998; Logan, 2004; Mamalakis, Tornaritis, & Kafatos, 2002; Peet, Murphy, Shay, & 
Horrobin, 1998). A study showed that pretreated mice with fish oil have developed less 
depressive symptoms through the suppression of neuroinflammation (Numata et al., 2015). 
Grayson et al. revealed in neuroimaging studies that lack of omega-3 implicates functional 
dysregulation at prefrontal cortical connectivity in monkeys (Grayson, Kroenke, Neuringer, & 
Fair, 2014). Notably, while it was shown that adolescents with MDD have a decreased frontal 
white matter integrity and worse connectivity within frontal lobe cortical networks (Connolly 
et al., 2013; Ho et al., 2014), Chhetry et al. found that fish oil supplementation could improve 
the connectivity, resulting in a reduction in depression symptom severity (Chhetry et al., 2016). 
The global importance of fatty acid elongation leaves of course space for additional regulatory 
implications in MDD. An unbalanced ratio of omega-6/omega-3 could contribute to obesity 
(Simopoulos, 2016), which has been demonstrated to increase the risk of depression (Luppino 
et al., 2010). Previously, MIR4646 was identified to be upregulated in peripheral blood from 
schizophrenic patients (Fan et al., 2015). Interestingly, several studies described deficiencies of 
omega-3 fatty acids in red blood cells membranes from schizophrenic patients (Peet, Shah, 
Selvam, & Ramchand, 2004; Reddy, Keshavan, & Yao, 2004). These common findings 
regarding the omega-3 role through the MIR4646 suggest a partially shared etiology of MDD 
and schizophrenia.  
No study previously described the importance of MIR4646. The conservation throughout 
miRNA-4646 stem-loop region and in particular the seed regions of the 5p and 3p mature 
sequences, along with pre-microRNA folding structure predictions in all of the investigated 
sequences and the conserved gene synteny suggests that this microRNA region is conserved 
from advent of the Simiiformes (monkey). The alignment of the reverse complement of 
miRNA-4646-3p to the miRNA-204 family is interesting as the reverse complement of 
miRNAs are speculated to be able to work in subtle regulatory activity and have some 
functional activity (Shao, Ma, Xu, Wang, & Meng, 2012).  Additionally, the mir-204 family 
has been investigated in association with schizophrenia and regulating non-coding RNA that 
affect neurotransmitter and ion channel gene sets (Cammaerts et al., 2015).  
Previous genome-wide studies showed evidence regarding altered DNA methylation in 
depression disorder, but mainly in monozygotic twin pairs, which are not reflecting the normal 
population (Byrne et al., 2013; Cordova-Palomera et al., 2015; Dempster et al., 2014). In our 
study, we could take into account both genetics and environmental components as an 
interconnected biological network, by investigating a population-based cohort. Moreover, the 
advantages of studying an adolescent population at risk of MDD instead of investigating 
individuals showing already clinical symptoms are numerous. Firstly, as a childhood episode 
of MDD substantially increases the risk of adverse outcomes in adulthood (Fergusson, Boden, 
& Horwood, 2007), it calls attention for early detection of MDD as a marker for severity of the 
underlying vulnerability. Studying a cohort at risk for MDD may thus provide an excellent 
platform for identifying epigenetic susceptibility factors that hold true for depressive disorders 
in general. Secondly, it can be argued that investigating developmental stages of 
psychopathology allows better isolating of causative factors for disease pathology, whereas 
analyses performed on adults that have had psychiatric problems for a long time are more likely 
to be burdened by confounding factors, e.g. antidepressants, alcohol or substance abuse, 
smoking, cardiovascular complications or even aging, all of which may influence methylation 
and could produce false outcomes (Breitling, Yang, Korn, Burwinkel, & Brenner, 2011; Menke 
& Binder, 2014; Zampieri et al., 2015).  
While DNA methylation is the best characterized mechanism of epigenetic regulation (Novik 
et al., 2002), different epigenetic mechanisms may act co-dependently and participate in cross-
regulating activities (Feil & Fraga, 2012; Iorio, Piovan, & Croce, 2010; Sun, Kennedy, & 
Nestler, 2013). Klengel et a. suggested that a better understanding of DNA methylation and its 
link to other epigenetic mechanisms will be important for understanding the epigenetic 
contribution to psychopathologies (Klengel, Pape, Binder, & Mehta, 2014). In this respect, our 
findings provide further grist to the mill that the epigenetic contribution to psychopathologies 
involve co-dependent and cross-regulatory processes of DNA methylation and miRNA activity. 
The DAWBA bands have been shown to be similar or identical to clinician-rated diagnoses in 
estimated effect sizes, significance levels and substantive conclusions regarding risk factor 
associations (Goodman et al., 2011). As the scores were not obtained in a face-to-face meeting 
of a clinician and the child, however, it cannot be completely excluded that an individual subject 
received an unrepresentative risk score assessment. Our study is also restricted by the limited 
number of individuals with higher risk-score assessments of MDD in both discovery (n=22) 
and replication group (n=13). Future studies including a high number of individuals would be 
of great value to confirm the results presented. Furthermore, in the replication data set, there 
were between-group differences in BMI z-score defined weight categories and in the use of 
contraceptive pills. Due to power issues, we were not able to adjust for these factors on the 
confirmatory association analysis between DNA methylation at cg04102384 and depression 
risk group. As such, this represents a limitation which could be a source of potential bias. In 
addition, the putative gene targets of MIR4646 were identified by computer algorithms. In vivo 
studies are needed to confirm the true gene targets of MIR4646 and its relation to the fatty acid 
elongation pathway. In addition, we were not able to confirm MIR4646 to be differentially 
expressed between adolescents at high risk of depression and controls in the qRT-PCR 
measurement. A possible reason could be the low fold change found of this miRNA levels 
between cases and controls in the discovery cohort (~21,4%) and the small sample size (n=27), 
an observation which is in line with another study that could not validate miRNA levels with 
less than four-fold change of expression (Fan et al., 2015). This limitation of qRT-PCR 
measurements could also contribute to explaining our inability to confirm the observed inverse 
correlation between methylation and expression at MIR4646-3p. Future studies should 
investigate to what extent miR-4646 is differentially expressed in individuals suffering from 
depression and its relation to the identified methylation locus.  
In summary we were able to reveal and validate a hypomethylated CpG site within MIR4646 
significantly associated with a modulated risk score for MDD in 223 adolescents. Notably, our 
study shows evidence that the DNA methylation changes of cg04102384 could regulate the 
gene expression pattern of MIR4646-3p. The performed functional analysis highlights a 
potential role of this miRNA in the regulation of fatty acids, with potential involvement in the 
conversion of omega-3 fatty acids. Our findings indicate that the dynamic interplay between 
DNA methylation and miRNA-transcription could have an elucidative mechanism on the 
pathogenesis of MDD and related diseases. 
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